Palvella Therapeutics (PVLA) Equity Ratio: 2013-2024
Historic Equity Ratio for Palvella Therapeutics (PVLA) over the last 11 years, with Sep 2024 value amounting to -4.26.
- Palvella Therapeutics' Equity Ratio fell 928.86% to -4.26 in Q3 2024 from the same period last year, while for Sep 2024 it was -4.26, marking a year-over-year decrease of 928.86%. This contributed to the annual value of -9.87 for FY2023, which is 3473.87% down from last year.
- As of Q3 2024, Palvella Therapeutics' Equity Ratio stood at -4.26, which was down 32.00% from -3.23 recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Equity Ratio registered a high of 0.51 during Q3 2023, and its lowest value of -9.87 during Q4 2023.
- Its 3-year average for Equity Ratio is -1.58, with a median of 0.29 in 2022.
- In the last 5 years, Palvella Therapeutics' Equity Ratio surged by 166.08% in 2020 and then crashed by 3,473.87% in 2023.
- Palvella Therapeutics' Equity Ratio (Quarterly) stood at 0.30 in 2020, then grew by 11.86% to 0.33 in 2021, then dropped by 11.51% to 0.29 in 2022, then tumbled by 3,473.87% to -9.87 in 2023, then plummeted by 928.86% to -4.26 in 2024.
- Its last three reported values are -4.26 in Q3 2024, -3.23 for Q2 2024, and -2.61 during Q1 2024.